Urticarial Vasculitis After First Denosumab Injection in an Osteoporotic Woman Diagnosed with Cushing’s Syndrome
Denosumab is a human-derived monoclonal immunoglobulin G2 antibody against the receptor activator of nuclear factor kappa B ligand, inhibiting the differentiation and function of osteoclast precursor cells by its antiosteoclastic action. Denosumab is approved for postmenopausal, glucocorti coid-indu...
Bewaard in:
| Hoofdauteurs: | , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Society of Endocrinology and Metabolism of Turkey
2022-09-01
|
| Reeks: | Endocrinology Research and Practice |
| Onderwerpen: | |
| Online toegang: | https://endocrinolrespract.org/index.php/pub/article/view/1123 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|